StartAngels Network

PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess patient's risk of suffering from cognitive disorders after a surgery.

Rebels 0.0% is a company dedicated to creating truly alcohol-free spirits, aiming to provide consumers with enjoyable alternatives for social drinking. By developing beverages that can be mixed with various drinks while containing no alcohol, Rebels 0.0% promotes a social mission to empower individuals in their choices regarding alcohol consumption. The brand emphasizes the importance of freedom of choice, allowing people to partake in social experiences without the effects of alcohol.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Peripal AG develops and commercializes patient aids for home care patients in the field of dialysis. Its products include PeriSafe, the novel patient assist device for Peritoneal dialysis and PERiPLEX, the peritoneal dialysis infection diagnostic. The company’s development focuses on Peripal System, a patient aid for the chronic patient population in dialysis that supports a critical therapy step. Its Peripal System includes manual connection of tubings. The company was founded in 2015 and is based in Zurich, Switzerland.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Peripal AG develops and commercializes patient aids for home care patients in the field of dialysis. Its products include PeriSafe, the novel patient assist device for Peritoneal dialysis and PERiPLEX, the peritoneal dialysis infection diagnostic. The company’s development focuses on Peripal System, a patient aid for the chronic patient population in dialysis that supports a critical therapy step. Its Peripal System includes manual connection of tubings. The company was founded in 2015 and is based in Zurich, Switzerland.

Diviac is the world’s leading online travel agency for scuba divers. A platform like no other, that inspires divers to dive more, travel more and take care of our oceans. Researching and booking a scuba holiday has never been easier, nor more enjoyable. Founded in December 2012 in Switzerland, Diviac is on a mission to energize and grow the overall scuba diving market for the benefit of all players. It already offers more dive destinations and more scuba holidays than any other travel company in the world. Catering to groups and individual travelers alike, Diviac uniquely combines best in class online booking experience with truly personalized expert advice, delivered by its global team of scuba travel experts. Diviac also cares deeply about sustainability and with the launch of Diviac Eco Travel, it now offers divers the opportunity to experience life-changing dive vacations that have an impact on the conservation of our oceans.

Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures. Medyria's goal is to develop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.

Creoptix AG is a Swiss company specializing in the development of optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery sector. Founded in 2009 and based in Wädenswil, the company provides advanced instrument sets tailored for fragment-based screening and binding analysis at low concentrations and slow dissociation kinetics. Their offerings include versatile sensors designed for carboxyl-coupling with a variety of molecules, as well as proprietary software that streamlines assay setup and data evaluation into a single platform. Creoptix aims to accelerate discovery in both industry and academic research by equipping life science researchers with innovative bioanalytical tools.

VirtaMed AG, based in Schlieren, Switzerland, develops and produces highly realistic surgical simulators specifically designed for medical training. Founded in 2007, the company offers a range of simulators for various medical specialties, including orthopedics, obstetrics and gynecology, laparoscopy, and urology, in addition to custom-made simulators. These simulators enable surgeons to train with original instruments in a safe and controlled environment, enhancing their skills before they operate on patients. VirtaMed’s advanced mixed reality technology provides sub-millimeter precision, allowing for progressively complex training scenarios that align with competency-based curricula. This innovative approach not only improves surgical education but also reduces costs associated with disposable materials during training, ultimately accelerating the time required for surgeons to achieve proficiency.